NEW YORK (GenomeWeb News) – WaferGen Biosystems has inked a deal to raise $1.5 million through a private placement of shares in its Malaysian subsidiary, WaferGen Biosystems Sdn. Bhd.

Investors in the round included Prima Mahawangsa, which is a wholly owned subsidiary of CAV Private Equity Management, and Expedient Equity Ventures.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.

Sponsored by

This webinar will detail a comprehensive strategy that a lab has put in place to evaluate  NGS oncology assays for genomic tumor profiling of plasma and tissue samples.